Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Ready
Primary summary from verified readiness
- Confidence
- 61% · fresh
- Computed at
- 2026-08-20T10:56:07.425474+00:00
- Claimed
- 85
- Reported
- 82
- Verified
- 74
- Gap
- +11
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-08-20
Track; not yet
- Why
- UNCOVERseq is a wet-lab/bioinformatics sequencing assay for CRISPR off-target nomination — a specialized life-sciences lab method with no direct build/buy/integrate surface for pragma.vision's AI-native commerce ecosystem; it belongs in the register as a domain signal only.
- Next
- No action beyond registry tracking; revisit only if a Pragma.Vision-adjacent biotech/gene-therapy platform surfaces a concrete need for CRISPR off-target risk-assessment tooling or if UNCOVERseq becomes a dependency cited by a tracked partner.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 5
- Tier 1
- 0
- Tier 2
- 1
- Tier 3
- 4
- Supports
- 3
- Contradicts
- 1
- Context
- 1
- Latest observed
- 2026-08-17
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-08-17 Reading moved from ready to ready.